Whan In Pharm Co.,Ltd. (KRX: 016580)
South Korea
· Delayed Price · Currency is KRW 11,980
-10 (-0.08%)
Dec 17, 2024, 3:30 PM KST
Whan In Pharm Co.,Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | - | - | -0 | -0 | 0 | - | Upgrade
|
| Revenue | 251,729 | 230,394 | 198,935 | 177,776 | 171,705 | 159,177 | Upgrade
|
| Revenue Growth (YoY) | 12.30% | 15.81% | 11.90% | 3.54% | 7.87% | 2.92% | Upgrade
|
| Cost of Revenue | 155,459 | 131,451 | 100,277 | 84,416 | 85,204 | 80,117 | Upgrade
|
| Gross Profit | 96,270 | 98,943 | 98,658 | 93,359 | 86,501 | 79,060 | Upgrade
|
| Selling, General & Admin | 65,964 | 64,470 | 61,948 | 55,849 | 51,936 | 49,410 | Upgrade
|
| Research & Development | 572.96 | 1,072 | 3,331 | 2,659 | 3,312 | 993.27 | Upgrade
|
| Other Operating Expenses | 1,282 | 1,311 | 1,273 | 1,238 | 1,093 | 1,022 | Upgrade
|
| Operating Expenses | 69,237 | 68,772 | 68,847 | 62,083 | 58,083 | 52,896 | Upgrade
|
| Operating Income | 27,033 | 30,170 | 29,810 | 31,276 | 28,418 | 26,165 | Upgrade
|
| Interest Expense | -21.36 | -22.66 | -51.88 | -51.55 | -31.42 | -20.28 | Upgrade
|
| Interest & Investment Income | 3,315 | 3,769 | 2,500 | 1,821 | 1,676 | 2,094 | Upgrade
|
| Earnings From Equity Investments | 784.9 | -1,006 | -201.08 | -61.86 | -31.74 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -227.88 | -141.12 | 343.44 | 223.56 | -201.3 | -61.56 | Upgrade
|
| Other Non Operating Income (Expenses) | 493.29 | 1,016 | 153.71 | 329.1 | 66.98 | 80.69 | Upgrade
|
| EBT Excluding Unusual Items | 31,377 | 33,785 | 32,555 | 33,536 | 29,897 | 28,258 | Upgrade
|
| Gain (Loss) on Sale of Investments | 496.38 | 1,895 | 925.83 | 794.08 | 1,299 | 730.46 | Upgrade
|
| Gain (Loss) on Sale of Assets | -301.57 | -1,160 | -1,897 | -6.22 | -63.52 | -714.08 | Upgrade
|
| Asset Writedown | 0 | -726.43 | -1,776 | -442.01 | -50.27 | -51.78 | Upgrade
|
| Pretax Income | 31,572 | 33,793 | 29,808 | 33,882 | 31,082 | 28,222 | Upgrade
|
| Income Tax Expense | 4,208 | 4,019 | 6,075 | 7,423 | 7,890 | 9,610 | Upgrade
|
| Earnings From Continuing Operations | 27,364 | 29,774 | 23,734 | 26,459 | 23,191 | 18,612 | Upgrade
|
| Minority Interest in Earnings | - | - | 187.76 | 201.09 | 196.49 | 83.97 | Upgrade
|
| Net Income | 27,364 | 29,774 | 23,921 | 26,660 | 23,388 | 18,696 | Upgrade
|
| Net Income to Common | 27,364 | 29,774 | 23,921 | 26,660 | 23,388 | 18,696 | Upgrade
|
| Net Income Growth | -0.38% | 24.47% | -10.27% | 13.99% | 25.10% | -13.11% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| EPS (Basic) | 1792.33 | 1950.23 | 1566.86 | 1746.22 | 1531.91 | 1224.59 | Upgrade
|
| EPS (Diluted) | 1792.00 | 1950.00 | 1566.86 | 1746.00 | 1531.91 | 1224.59 | Upgrade
|
| EPS Growth | -0.40% | 24.45% | -10.26% | 13.98% | 25.10% | -13.09% | Upgrade
|
| Free Cash Flow | -4,163 | -7,334 | -16,799 | 30,931 | 14,767 | 21,971 | Upgrade
|
| Free Cash Flow Per Share | -272.70 | -480.39 | -1100.32 | 2025.98 | 967.21 | 1439.08 | Upgrade
|
| Dividend Per Share | 300.000 | 300.000 | 300.000 | 300.000 | 300.000 | 300.000 | Upgrade
|
| Gross Margin | 38.24% | 42.95% | 49.59% | 52.52% | 50.38% | 49.67% | Upgrade
|
| Operating Margin | 10.74% | 13.10% | 14.99% | 17.59% | 16.55% | 16.44% | Upgrade
|
| Profit Margin | 10.87% | 12.92% | 12.02% | 15.00% | 13.62% | 11.75% | Upgrade
|
| Free Cash Flow Margin | -1.65% | -3.18% | -8.44% | 17.40% | 8.60% | 13.80% | Upgrade
|
| EBITDA | 34,912 | 36,830 | 34,657 | 35,478 | 32,488 | 30,065 | Upgrade
|
| EBITDA Margin | 13.87% | 15.99% | 17.42% | 19.96% | 18.92% | 18.89% | Upgrade
|
| D&A For EBITDA | 7,879 | 6,659 | 4,847 | 4,202 | 4,070 | 3,900 | Upgrade
|
| EBIT | 27,033 | 30,170 | 29,810 | 31,276 | 28,418 | 26,165 | Upgrade
|
| EBIT Margin | 10.74% | 13.10% | 14.98% | 17.59% | 16.55% | 16.44% | Upgrade
|
| Effective Tax Rate | 13.33% | 11.89% | 20.38% | 21.91% | 25.39% | 34.05% | Upgrade
|
| Advertising Expenses | - | 12,359 | 10,387 | 9,519 | 7,069 | 4,930 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.